Tacrolimus for the treatment of rheumatoid arthritis: are broad-based immunosuppressants still valid?

Author： Schwartz Benjamin D   Mengle-Gaw Laurel J  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.1, Iss.6, 2006-12, pp. : 661-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

By Lee YH   Woo J-H   Choi SJ   Ji JD   Bae S-C   Song GG  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 4, 2010-08 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

Treatment of elderly rheumatoid arthritis

By Tutuncu Zuhre   Kavanaugh Arthur  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 313-319

Future Medicine

Access to resources Recommend Favorite

Treatment of the elderly rheumatoid arthritis patient

By Melikterminas Edward   Ranganath Veena   Furst Daniel E  

Future Rheumatology, Vol. 3, Iss. 3, 2008-06 ,pp. : 235-238

Future Medicine

Access to resources Recommend Favorite

Treatment of Rheumatoid Arthritis with a Peptide Diet

By Holst-Jensen S.E   Pfeiffer-Jensen M   Monsrud M   Tarp U   Buus A   Hessov I   Thorling E   Stengaard-Pedersen K  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 5, 1998-10 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite

Treatment of rheumatoid arthritis in the third millennium

By Skapenko Alla   Kalden Joachim R.   Schulze-Koops Hendrik  

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 5, 2001-10 ,pp. : 249-254

Informa Healthcare

Access to resources Recommend Favorite